journal article·2025-03

Borrow Strength to Exert: Low‐Crystallinity Prussian Blue for Reduction Overload Enhanced Photothermal Therapy

Yuxin Yao, Junlie Yao, Shiyi Xiong, Yabing Sun, Liangxue Lai, Chenglong He, Shaohua Jiang, Kareem Elsayad, Hao Peng, Aiguo Wu, Fang Yang

Small· Volume 21· Issue 9
Publisher page

Abstract

Abstract The strategy “Borrow strength to exert” in Sun Tzu's Art of War refers to borrowing external forces to withstand the enemy. Inspired by this, applying this thought to cancer treatment can achieve a more efficient therapeutic effect. Therefore, a fulcrum to borrow the force is vital and significant. Compared with normal cells, tumor cells are more sensitive to redox stress owing to their abnormal redox metabolism. Herein, a regulatory protocol based on chloroauric acid (HAuCl 4 ) is proposed to prepare small‐size and low‐crystallinity Prussian blue nanoparticles (LcPB NPs). Notably, LcPB NPs possess higher superoxide dismutase (SOD)‐like enzyme activity to induce reduction overload and destroy metabolic processes and organelle functions, which leverages the redox status defect in tumors as the fulcrum. Due to the down‐regulation of heat shock proteins (HSPs) mediated by redox imbalance, the inherent photothermal therapy (PTT) mode of LcPB NPs effectively inhibits tumor growth and disrupts calcium homeostasis. Additionally, LcPB NPs can improve the anticancer effect by inhibiting symbiotic bacteria. Meanwhile, their magnetic and optical response performance empowers magnetic resonance imaging (MRI) and photoacoustic imaging (PAI) for tumor diagnosis. Therefore, this work executing the strategy “Borrowing strength to exert” by disturbing the redox balance represents a new antineoplastic paradigm.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cixi Institute of Biomedical Engineering Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology CAS Key Laboratory of Magnetic Materials and Devices Zhejiang Engineering Research Center for Biomedical Materials Ningbo Institute of Materials Technology and Engineering Chinese Academy of Sciences Ningbo 315201 P. R. China

Cixi Biomedical Research Institute Wenzhou Medical University Ningbo 315300 P. R. China

Jiangsu Co‐Innovation Center of Efficient Processing and Utilization of Forest Resources International Innovation Center for Forest Chemicals and Materials College of Materials Science and Engineering Nanjing Forestry University Nanjing 210037 P. R. China

Division of Anatomy Center for Anatomy and Cell Biology Medical University of Vienna Vienna A‐1090 Austria

Funding

National Natural Science Foundation of China · Youth Innovation Promotion Association · Chinese Academy of Sciences · International Cooperation Project of Ningbo City

References (34)

Show source-provided references
1. 10.1016/j.freeradbiomed.2018.01.02310.1016/j.freeradbiomed.2018.01.023 ↗
2. 10.1155/2019/617580410.1155/2019/6175804 ↗
3. 10.1073/pnas.231167312010.1073/pnas.2311673120 ↗
4. 10.1155/2021/997188510.1155/2021/9971885 ↗
5. 10.1002/smll.20231001810.1002/smll.202310018 ↗
6. 10.1016/j.semcancer.2022.10.00510.1016/j.semcancer.2022.10.005 ↗
7. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
8. 10.1021/acsabm.1c0028510.1021/acsabm.1c00285 ↗
9. 10.7150/thno.3378310.7150/thno.33783 ↗
10. 10.1002/adma.20210403710.1002/adma.202104037 ↗
11. 10.1098/rsob.21001310.1098/rsob.210013 ↗
12. 10.1016/j.jre.2020.06.01910.1016/j.jre.2020.06.019 ↗
13. 10.1038/s41568-023-00594-210.1038/s41568-023-00594-2 ↗
14. 10.1126/science.aay918910.1126/science.aay9189 ↗
15. 10.1016/j.addr.2024.11545810.1016/j.addr.2024.115458 ↗
16. 10.1016/j.cell.2022.02.02710.1016/j.cell.2022.02.027 ↗
17. 10.1126/science.aah504310.1126/science.aah5043 ↗
18. 10.1016/j.matdes.2023.11223110.1016/j.matdes.2023.112231 ↗
19. 10.1039/D3NR01741A10.1039/D3NR01741A ↗
20. 10.1016/j.biomaterials.2022.12198010.1016/j.biomaterials.2022.121980 ↗
21. 10.1021/acsnano.2c0283210.1021/acsnano.2c02832 ↗
22. 10.3389/fimmu.2022.89135110.3389/fimmu.2022.891351 ↗
23. 10.1021/acsami.1c0302710.1021/acsami.1c03027 ↗
24. 10.1016/j.ccr.2020.21339310.1016/j.ccr.2020.213393 ↗
25. 10.1002/anie.20110519010.1002/anie.201105190 ↗
26. 10.1021/acsanm.1c0061710.1021/acsanm.1c00617 ↗
27. 10.1002/aenm.20210235610.1002/aenm.202102356 ↗
28. 10.1038/s41594-024-01309-310.1038/s41594-024-01309-3 ↗
29. 10.1007/s12015-015-9628-210.1007/s12015-015-9628-2 ↗
30. 10.1155/2016/623564110.1155/2016/6235641 ↗
31. 10.1016/j.ccell.2023.04.01610.1016/j.ccell.2023.04.016 ↗
32. 10.1182/blood.202101278810.1182/blood.2021012788 ↗
33. 10.1016/j.addr.2023.11502010.1016/j.addr.2023.115020 ↗
34. 10.1073/pnas.230615212010.1073/pnas.2306152120 ↗